Guardian Pharmacy Services, Inc.
corporate_fare Company Profile
Guardian Pharmacy Services, Inc. (NYSE:GRDN) is a publicly traded company in the Life Sciences sector. Wiseek monitors GRDN SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Guardian Pharmacy Q4 Revenue Beats Estimates, 2026 EBITDA Outlook Raised by Up to 5%
- Guardian Pharmacy Reports Strong 2025 Results, Swings to Profitability with 17.9% Revenue Growth
- Guardian Pharmacy Reports Strong Q4 & FY25 Results, Raises 2026 Adjusted EBITDA Guidance
- Guardian Pharmacy Services Projects Low Double-Digit EBITDA Growth for 2026 Despite IRA Impact
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$1.45B
Net Income
$49.22M
Op. Cash Flow
$100.25M
Free Cash Flow
$86.84M
Gross Profit
$292.72M
Operating Income
$72.7M
Cash & Equivalents
$65.62M
Total Debt
$0
Debt / Equity
0.00×
Net Margin
3.4%
Source: 10-K · filed 2026-03-11 · accession 0001193125-26-102172
show_chartPrice Chart
Loading chart...
feed GRDN - Filings & News (Page 2)
GRDN
Mar 11, 2026, 4:41 PM EDT
Price at Filing:
$33.05
Real-time Price:
$43.09
Change:
+$10.04 (+30%)
Market Cap:
$2.728B
GRDN
Mar 11, 2026, 4:15 PM EDT
Price at Filing:
$34.00
Real-time Price:
$43.09
Change:
+$9.09 (+27%)
Market Cap:
$2.728B
GRDN
Mar 11, 2026, 4:11 PM EDT
Price at Filing:
$34.00
Real-time Price:
$43.09
Change:
+$9.09 (+27%)
Market Cap:
$2.728B
GRDN
Jan 13, 2026, 4:41 PM EST
Price at Filing:
$31.26
Real-time Price:
$43.09
Change:
+$11.83 (+38%)
Market Cap:
$2.728B